Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 10, 1999, Pages 1153-1167

  Sadlon, Tim J ^a   Dell'Oso, Tania ^a   Surinya, Kathy H ^a   May, Brian K ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

ALAS2 expression; Erythropoiesis; Role of heme; Transcriptional and post transcriptional control; X linked sideroblastic anemia

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PORPHYRIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR;

CELL DIFFERENTIATION; ENZYME REGULATION; ERYTHROPOIESIS; GENE CONTROL; HEME SYNTHESIS; HUMAN; IRON TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIDEROBLASTIC ANEMIA; TATA BOX; TRANSCRIPTION REGULATION;

EID: 0032832182     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00073-4     Document Type: Article

References (102)

1. Cross M.A., Enver T. The lineage commitment of hematopoietic progenitor cells. Current Opinions in Genetics and Development. 7:1997;609-613.
2. Podkolodnaya O.A., Stepanenko I.L. Mechanisms of transcription regulation of erythroid-specific genes. Molecular Biology. 31:1997;562-574.
3. Cheng T., Shen H., Giokas D., Gere J., Tenen D.G., Scadden D.T. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proceedings of the National Academy of Science, USA. 93:1996;13,158-13,163.
4. Klingmuller U. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells-signals emanating from the erythropoietin receptor. European Journal of Biochemistry. 249:1997;637-647.
5. Baron M.H. Transcriptional control of globin gene switching during vertebrate development. Biochimica et Biophysica Acta. 1351:1997;51-72.
6. Higgs D.R., Sharpe J.A., Wood W.G. Understanding α-globin gene expression: A step towards effective gene therapy. Seminars in Hematology. 35:1998;93-104.
7. Harigae H., Suwabe N., Weinstock P.H., Nagai M., Fujita H., Yamamoto M., Sassa S. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific aminolevulinate synthase gene. Blood. 91:1998;798-805.
8. Muta K., Krantz S.B. Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. Journal of Cellular Physiology. 163:1995;38-50.
9. Bottomley S.S. Sideroblastic anemias. Lee G.R., Bithell T.C., Foerster J., Athens J.W., Lukens J.N. Wintrobe's Clinical Hematology. 10th ed. 1998;1022-1045 Williams and Willeins, Baltimore.
10. Taketani S., Kohno H., Furukawa T., Tokunaga R. Involvement of peripheral-type benzodiazepine receptor in the intracellular transport of heme and porphyrins. Journal of Biochemistry. 117:1995;875-880.
11. Taketani S., Adachi Y., Kohno H., Ikehara S., Tokunaga R., Ishii T. Molecular characterisation of a newly identified heme-binding protein induced during differentiation of murine erythroleukemia cells. Journal of Biological Chemistry. 273:1998;31,388-31,394.
12. Shimada Y., Okuno S., Kawai A., Shinomiya H., Saito A., Suzuki M., Omori Y., Nishino N., Kanemoto N., Fujiwara T., Horie M., Takahashi E. Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerellar ataxia. Journal of Human Genetics. 43:1998;115-122.
13. Sutherland G.R., Baker E., Callen D.F., Hyland V.J., May B.K., Bawden M.J., Healy H.M., Borthwick I.A. 5-Aminolevulinate synthase is at 3p21 and thus not the primary defect in X-linked sideroblastic anaemia. American Journal of Genetics. 43:1988;331-335.
14. May B.K., Dogra S.C., Sadlon T.J., Bhasker C.R., Cox T.C., Bottomley S.S. Molecular regulation of heme biosynthesis in higher vertebrates. Progress in Nucleic Acid Research and Molecular Biology. 51:1995;1-51.
15. Cox T.C., Bawden M.J., Abraham N.G., Bottomley S.S., May B.K., Baker E., Chen L.Z., Sutherland G.R. Erythroid 5-aminolevulinate synthase is located on the X chromosome. American Journal of Human Genetics. 46:1990;107-111.
16. Bishop D.F., Henderson A.S., Astrin K.H. Human δ-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics. 7:1990;207-214.
17. Braidotti G., Borthwick I.A., May B.K. Identification of regulatory sequences in the gene for 5-aminolevulinate synthase from rat. Journal of Biological Chemistry. 268:1993;1109-1117.
18. Fukuda Y., Fujita H., Garbaczewski L., Sassa S. Regulation of β-globin mRNA accumulation by heme in dimethyl sulfoxide (DMSO)-sensitive and DMSO-resistant murine erythroleukemia cells. Blood. 83:1994;1662-1667.
19. Porcher C., Picat C., Daegelen D., Beaumont C., Grandchamp B. Functional analysis of DNase-I hypersensitive sites at the mouse porphobilinogen deaminase gene locus: different requirements for position-independent expression from its two promoters. Journal of Biochemistry. 270:1995;17,368-17,374.
20. Spadaccini A., Tilbrook P.A., Sarna M.K., Crossley M., Bieker J.J., Klinken S.P. Transcription factor erythroid Krüppel-like factor (EKLF) is essential for the erythropoietin-induced hemoglobin production but not for proliferation, viability, or morphological maturation. Journal of Biological Chemistry. 273:1998;23,793-23,798.
21. Conboy J.G., Cox T.C., Bottomley S.S., Bawden M.J., May B.K. Human erythroid 5-aminolevulinate synthase: gene structure and species-specific differences in alternative RNA splicing. Journal of Biological Chemistry. 267:1992;18,753-18,758.
22. Yin X., Dailey H.A. Erythroid 5-aminolevulinate synthase is required for erythroid differentiation in mouse embryonic stem cells. Blood Cells, Molecules and Diseases. 24:1998;41-53.
23. Meguro K., Igarashi K., Yamamoto M., Fujita H., Sassa S. The role of the erythroid δ-aminolevulinate synthase gene expression in erythroid heme synthesis. Blood. 86:1995;940-948.
24. Palma J.F., Gao X., Lin C-H., Wu S., Solomon W.B. Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2. Blood. 84:1994;1288-1297.
25. Solomon W.B., Lin C-H., Palma J., Gao X.Y., Wu S. Suppression of a cellular differentiation program by phorbol ester coincides with inhibition of binding a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene. Journal of Biological Chemistry. 268:1993;5089-5096.
26. Surinya K.H., Cox T.C., May B.K. Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. Journal of Biological Chemistry. 272:1997;26,585-26,594.
27. Gregory R.C., Taxman D.J., Seshasayee D., Kensinger M.H., Bieker J.J., Wojchowski D.M. Functional interaction of GATA-1 with erythroid Krüppel-like factor and SP1 at defined erythroid promoters. Blood. 87:1996;1793-1801.
28. Fong T.C., Emerson B.M. The erythroid-specific protein cGATA-1 mediates distal enhancer activity through a specialised β-globin TATA-box. Genes and Development. 6:1992;521-532.
29. Tsai S.F., Strauss E., Orkin S.H. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes & Development. 5:1991;919-931.
30. Youssoufian H. Further characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor-evidence for stage-specific regulation. Blood. 83:1994;1428-1435.
31. Mignotte V., Eleouet J.F., Raich N., Romeo P.H. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proceedings of the National Academy of Science, USA. 86:1989;6548-6552.
32. Magness S.T., Tugores A., Diala E.S., Brenner D.A. Analysis of the human ferrochelatase promoter in transgenic mice. Blood. 92:1998;320-328.
33. Max-Audit I., Eleovet J.F., Romeo P.H. Transcriptional regulation of the pyruvate kinase erythroid-specific promoter. Journal of Biological Chemistry. 268:1993;5431-5437.
34. Terajima M., Nemoto Y., Obinata M. Inducible expression of erythroid-specific mouse glycophorin gene is regulated by proximal elements and locus control region-like sequence. Journal of Biochemistry. 118:1995;593-600.
35. Miller I.J., Bieker J.J. A novel erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Molecular and Cellular Biology. 13:1993;2776-2786.
36. Crossley M., Whitelaw E., Perkins A., Williams G., Fujiwara Y., Orkin S.H. Isolation and characterisation of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Molecular and Cellular Biology. 16:1996;1695-1705.
37. Perkins A.C., Sharpe A.H., Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACC-transcription factor EKLF. Nature. 375:1995;318-322.
38. Nuez B., Michalovich D., Bygrave A., Ploemacher R., Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature. 375:1995;316-318.
39. Donze D., Townes T.M., Bieker J.J. Role of erythroid Krüppel-like factor in human γ to β-globin gene switching. Journal of Biological Chemistry. 270:1995;1955-1959.
40. Wijgerde M., Gribnau J., Trimborn T., Nuez B., Philipsen S., Grosveld F., Fraser P. The role of EKLF in human β-globin gene competition. Genes and Development. 10:1996;2894-2902.
41. Bieker J.J., Southwood C.M. The erythroid Krüppel-like factor transactivation domain is a critical component for cell specific inducibility of a beta-globin promoter. Molecular Cellular Biology. 15:1995;852-860.
42. Gillemans N., Tewari R., Lindeboom F., Rottier R., de Wit T., Wijgerde M., Grosveld F., Philipsen S. Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the beta-globin locus control region in vivo. Genes and Development. 12:1998;2863-2873.
43. Tewari R., Gillemans N., Wijgerde M., Nuez B., von Lindern M., Grosveld F., Philipsen S. Erythroid Krüppel-like factor (EKLF) is active in primitive and definitive erythroid cells and is required for the function of 5′ HS3 of the beta-globin locus control region. EMBO Journal. 17:1998;2334-2341.
44. Bottomley S.S., Muller-Eberhard U. Pathophysiology of heme synthesis. Seminars in Hematology. 25:1988;282-302.
45. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 89:1997;1-25.
46. Schoenhaut D.S., Curtis P.J. Structure of a mouse erythroid 5-aminolevulinate synthase gene and mapping of erythroid-specific DNAse 1 hypersensitive sites. Nucleic Acid Research. 17:1989;7013-7028.
47. Lacronique V., Lopez S, Miquerol L., Porteu A., Kahn A., Raymond-Jean M. Identification and functional characterization of an erythroid-specific enhancer in the L-type pyruvate kinase gene. Journal of Biological Chemistry. 270:1995;14,989-14,997.
48. Nemoto Y., Terajima M., Shoji W., Obinata M. Regulatory function of delta/YY-1 on the locus control region-like sequence of mouse glycophorin gene in erythroleukemia cells. Journal of Biological Chemistry. 271:1996;13,542-13,548.
49. McDevitt M.A., Fujiwara Y., Shivdasani R.A., Orkin S.H. An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. Proceedings of the National Academy of Sciences, USA. 94:1997;7976-7981.
50. Onodera K., Takahashi S., Nishimura S., Ohta J., Motohashi H., Yomogida K., Hayashi N., Engel J.D., Yamamoto M. GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proceedings of the National Academy of Sciences, USA. 94:1997;4487-4492.
51. Beaumont C., Seyhan A., Yachou A.K., Grandchamp B., Jones R. Mouse ferritin H subunit gene - functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells. Journal of Biological Chemistry. 269:1994;20,281-20,288.
52. O'Prey J., Ramsay S., Chambers I., Harrison P.R. Transcriptional up-regulation of the mouse cytosolic glutathione peroxidase gene in erythroid cells is due to a tissue-specific 3′ enhancer containing functionally important CACC/GT motifs and binding sites for GATA and Ets transcription factors. Molecular & Cellular Biology. 13:1993;6290-6303.
53. Surinya K.H., Cox T.C., May B.K. Identification and characterisation of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. Journal of Biological Chemistry. 273:1998;16,798-16,809.
54. Orkin S.H. Transcription factors and hematopoietic development. Journal of Biological Chemistry. 270:1995;4955-4958.
55. Lin C.S., Lim S.K., Dagati V., Crostantini F. Differential effects of an erythropoietin receptor disruption on primitive and definitive erythropoiesis. Genes and Development. 10:1996;154-164.
56. Wu H., Liu X., Jaenisch R., Lodish K.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:1995;59-67.
57. Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:1998;397-409.
58. Tilbrook P.A., Ingley E., Williams J.H., Hibbs M.L., Klinken S.P. Lyn Tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO Journal. 16:1997;1610-1619.
59. Busfield S.J., Chappell D.S., Jennings G., Trengove N.J., Riches K.J., Callus B.A., Tilbrook P.A., Klinken S.P. Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cells. Cellular growth and differentiation. 6:1995;429-437.
60. Busfield S.J., Tilbrook P.A., Callus B.A., Spadaccini A., Kuhn L., Klinken S.P. Complex regulation of transferrin receptors during erythropoietin-induced differentiation of J2E erythroid cells - elevated transcription and mRNA stabilisation produce only a modest rise in protein content. European Journal of Biochemistry. 249:1997;77-84.
61. maj-globin promoter. Journal of Biological Chemistry. 270:1995;6619-6627.
62. Busfield S.J., Spadaccini A., Riches K.J., Tilbrook P.A., Klinken S.P. The major erythroid DNA-binding protein GATA-1 is stimulated by erythropoietin but not by chemical inducers of erythroid differentiation. European Journal of Biochemistry. 230:1995;475-480.
63. Daylot N., Fibach E., Ronchi A., Rachmilewitz E.A., Ottolenghi S., Oppenheim A. Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Research. 21:1993;4031-4037.
64. Nagai T., Igarashi K., Akasaka J., Furuyama K., Fujita H., Hayashi N., Yamamoto M., Sassa S. Regulation of NF-E2 activity in erythroleukemia cell differentiation. Journal of Biological Chemistry. 273:1998;5358-5365.
65. Crossley M., Orkin S.H. Phosphorylation of the erythroid transcription factor GATA-1. Journal of Biological Chemistry. 269:1994;16,589-16,596.
66. Ouyang L., Chen X.Y., Bieker J.J. Regulation of erythroid Krüppel-like factor (EKLF) transcriptional activity by phosphorylation of a protein kinase casein kinase II site within its interaction domain. Journal of Biological Chemistry. 273:1998;23,019-23,025.
67. Zhang W., Bieker J.J. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proceedings of National Academy of Sciences, USA. 95:1998;9855-9860.
68. Boyes J., Byfield P., Naatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 396:1998;594-598.
69. Kuo M-H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626.
70. Merika M., Orkin S.H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF. Molecular and Cellular Biology. 15:1995;2437-2447.
71. Tsang A.P., Visvader J.E., Turner C.A., Fjiwara Y., Yu C., Weiss M., Crossley M., Orkin S.H. Fog, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell. 90:1997;109-119.
72. Ellis J., Tan-Un K.C., Harper A., Michalovich D., Yannoutsos N., Philipsen S., Grosveld F. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human β-globin locus control region. EMBO Journal. 15:1996;562-568.
73. Fraser P., Grosveld F. Locus control regions, chromatin activation and transcription. Current Opinion in Cell Biology. 10:1998;361-365.
74. Dillon N., Trimborn T., Strouboulis J., Fraser P., Grosveld F. The effect of distance on long range chromatin interactions. Molecular Cell. 1:1997;131-139.
75. Hebbes T.R., Clayton A.L., Thorne A.W., Crane-Robinson C. Core histone hyperacetylation co-maps with generalised DNase 1sensitivity in the chicken β-globin chromosomal domain. EMBO Journal. 13:1994;1823-1830.
76. Blobel G.A., Nakajima T., Eckner R., Montminy M., Orkin S.H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proceedings of the National Academy of Sciences, USA. 95:1998;2061-2066.
77. Finch C. Regulators of iron balance in humans. Blood. 84:1994;1697-1702.
78. Cox T.C., Bawden M.J., Martin A., May B.K. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO Journal. 7:1991;1891-1902.
79. Henderson B.R. Iron regulatory proteins 1 and 2. Bioassays. 18:1996;739-746.
80. Menotti E., Henderson B.R., Kuhn L.C. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. Journal of Biological Chemistry. 273:1998;1821-1824.
81. Melefors O., Goossens B., Johansson H.E., Stripecke R., Gray N.K., Hentze M.W. Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells. Journal of Biological Chemistry. 268:1993;5974-5978.
82. Bhasker C.R., Burgiel G., Neupert B., Emery-Goodman A., Kuhn L.C., May B.K. The putative iron-responsive element in the human erythroid 5-aminolevulinate synthase mRNA mediates translational control. Journal of Biological Chemistry. 268:1993;12,699-12,705.
83. Muckenthaler M., Gray N.K., Hentze M.W. IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Molecular Cell. 2:1998;383-388.
84. Chen J.J., London I.M. Regulation of protein synthesis by heme-regulated e1F-alpha kinase. Trends in Biochemical Sciences. 20:1995;105-108.
85. Chan R.Y., Seiser C., Schulman H.M., Kuhn L.C., Ponka P. Regulation of transferrin receptor mRNA expression: Distinct regulatory features in erythroid cells. European Journal of Biochemistry. 220:1994;683-692.
86. Chan L-N., Gerhardt E.M. Transferrin receptor is hyperexpressed and transcriptionally regulated in differentiating erythroid cells. Journal of Biological Chemistry. 267:1992;8254-8259.
87. Weiss G., Houston T., Kastner S., Johrer K., Grunewald K., Brock J.H. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and up-regulation of transferrin receptor expression in erythroid cells. Blood. 89:1997;680-687.
88. Lathrop J.T., Timko M.P. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science. 259:1993;522-525.
89. Smith S.J., Cox T.M. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme. Cellular and Molecular Biology. 43:1997;103-114.
90. Bottomley S.S., May B.K., Cox T.C., Cotter P.D., Bishop D.F. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia. Journal of Bioenergetics & Biomembranes. 27:1995;161-168.
91. Yaouanq J., Grosbois B., Jouanelle A.M., Goasguen J., Leblay R. Haemochromatosis Cys 282 Tyr mutation in pyridoxine-responsive sideroblastic anaemia. Lancet. 349:1997;1475-1476.
92. Bottomley S.S. Secondary iron overload disorders. Seminars in Hematology. 35:1998;77-86.
93. Edgar A.J., Vidyatilake H.M.S., Wickramasinghe S.N. X-linked sideroblastic anaemia due to a mutation in the erythroid 5-aminolevulinate synthase gene leading to an arginine (170) to leucine substitution. European Journal of Haematology. 61:1998;55-58.
94. Edgar A.J., Wickramasinghe S.N. Hereditary sideroblastic anemia due to a mutation in exon 10 of the erythroid 5-aminolevulinate synthase gene. British Journal of Hematology. 100:1997;389-392.
95. Furuyama K., Fujita H., Nagai T., Yomogida K., Munakata H., Kondo M., Kimura A., Kuramoto A., Hayashi N., Yamamoto M. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood. 90:1997;822-830.
96. Cox T.C., Bottomley S.S., Wiley J.S., Bawden M.J., Matthews C.S., May B.K. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. New England Journal of Medicine. 330:1994;675-679.
97. Cotter P.D., Rucknagel D.L., Bishop D.F. X-Linked sideroblastic anemia: identification of the mutation in the erythroid-specific δ-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood. 84:1994;3915-3924.
98. Prades E., Chambon C., Dailey T.A., Dailey H.A., Briere J., Grandchamp B. A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia. Human Genetics. 95:1995;424-428.
99. Tuckfield A., Ratnaike S., Hussein, Metz J. A novel form of sideroblastic anaemia with macrocytosis. British Journal of Haematology. 97:1997;279-285.
100. Aoki Y., Muranaka S., Nakabayashi K., Veda Y. δ-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia: hypercatabolism caused by increased susceptibility to the controlling protease. Journal of Clinical Investigation. 64:1979;1196-1203.
101. Brownlie A., Donovan A., Pratt S.J., Paw B.H., Oates A.C., Brugnara C., Witkowaska H.E., Sassa S., Zon L.I. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nature Genetics. 20:1998;244-251.
102. Cox T.C., Kozman H.M., Raskind W.H., May B.K., Mulley J.C. Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anaemia. Human Molecular Genetics. 1:1995;639-641.